ctrl K

Watchlist Price Alert

DiaMedica Therapeutics In... (DMAC)

NASDAQ: DMAC · Real-Time Price · USD

4.18

0.09 (2.20%)

At close: Jun 06, 2025, 9:59 AM

DiaMedica Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	500K	n/a	n/a
Cost of Revenue	n/a	30K	25K	24K	21K	21K	n/a	4K	2.21K
Gross Profit	n/a	-30K	-25K	-24K	-21K	-21K	500K	-4K	-2.21K
Operating Income	-26.68M	-21.27M	-14M	-13.65M	-12.7M	-11.59M	-6.76M	-4.52M	-2.48M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.73K
Pretax Income	-24.41M	-19.34M	-13.65M	-13.56M	-12.27M	-10.62M	-5.65M	-4.26M	-2.2M
Net Income	-24.44M	-19.38M	-13.68M	-13.59M	-12.29M	-10.65M	-5.73M	-4.26M	-2.22M
Selling & General & Admin	7.62M	8.16M	6.16M	4.88M	4.39M	3.69M	2.74M	1.31M	718.04K
Research & Development	19.06M	13.11M	7.84M	8.77M	8.31M	7.9M	4.52M	3.21M	1.76M
Other Expenses	n/a	n/a	353K	82K	-205K	-856K	-68K	6K	221.9K
Operating Expenses	26.68M	21.27M	14M	13.65M	12.49M	10.74M	6.05M	4.28M	2.48M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	48.38K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	21.27M	14M	13.65M	12.49M	10.74M	6.05M	4.28M	2.48M
Income Tax Expense	30K	43K	28K	28K	27K	31K	80K	-9K	22.31K
Shares Outstanding (Basic)	40.4M	32.57M	26.44M	20.77M	15.68M	11.99M	7.74M	5.94M	4.74M
Shares Outstanding (Diluted)	40.4M	32.57M	26.44M	20.77M	15.68M	11.99M	7.74M	5.94M	4.74M
EPS (Basic)	-0.6	-0.6	-0.52	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47
EPS (Diluted)	-0.6	-0.6	-0.52	-0.65	-0.78	-0.89	-0.74	-0.72	-0.47
EBITDA	-24.38M	-19.31M	-13.98M	-13.62M	-12.24M	-10.6M	-5.64M	-4.26M	-2.15M
EBIT	-24.41M	-19.34M	-13.65M	-13.56M	-12.27M	-10.62M	-5.55M	-4.26M	-2.15M
Depreciation & Amortization	n/a	30K	25K	24K	21K	21K	15K	4K	2.21K